
Exhaled SARS-CoV-2 quantified by face-mask sampling in hospitalised patients with COVID-19
This paper, published in the Journal of Infection and produced by researchers part-funded under Theme 4 of the PROTECT study, presents a new method for detecting SARS-CoV-2 (the virus that causes COVID-19) in exhaled breath using sampling strips fixed within face coverings.
Of the 66 hospitalised patients who took part in the study, 38% tested positive by the face mask sampling method within 24 hours of a positive result from a COVID-19 PCR test administered by nasal swab. Higher viral loads in the face mask samples were associated with the development of more severe symptoms.
Related
COVID-19 outbreak rates and infection attack rates associated with the workplace: a descriptive epid...
Potential contribution of vaccination uptake to occupational differences in risk of SARS-CoV-2: anal...
The effect of the ventilation rate on exposure to SARS-CoV-2 in a room with mixing ventilation





0 Comments